ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HYL Hyloris Pharmaceuticals SA

11.70
0.00 (0.00%)
Last Updated: 06:30:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Hyloris Pharmaceuticals SA EU:HYL Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 11.70 11.80 13.00 0.00 06:30:00

Rule 8 - (Hamleys plc)

18/07/2003 12:50pm

UK Regulatory


RNS Number:7158N
ING Bank N.V. London Branch
18 July 2003


FORM 8.1/8.3



Lodge with a RIS or Newstrack if appropriate and the Takeover Panel.  Use a
separate form for each class of securities in which dealings have been made.



Date of Disclosure


18 July, 2003



DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS
AND MERGERS



Date of dealing


17 July, 2003



Dealing in (name of company)


Hamleys plc



1. Class of securities (eg ordinary shares)


5 5/9 pence Ordinary Shares



2. Details of dealings



Children's Stores Holdings Limited ("Children's Stores") has agreed to sell to
Soldier Limited its entire interest in Hamleys plc's existing issued share
capital amounting to, in aggregate, 3,513,548 Hamleys Shares for settlement on 8
August 2003.  In addition, in the light of Children's Stores announcement dated
17 July 2003, the irrevocable undertakings to accept Children's Stores proposed
offer from certain of Hamleys' institutional shareholders in respect of, in
aggregate, 940,400 Hamleys Shares will lapse.



Save as otherwise disclosed, as at the date and time of this announcement,
Children's Stores and parties acting in concert with it neither own nor control
any interest in the existing issued share capital of Hamleys plc.



3. Resultant total of the same class owned or controlled (and percentage of
class)



Owned
-                                                    -%



Subject to irrevocable undertakings
-                                                    -%



Total

-                                                    -%





4. Party making disclosure


ING Bank N.V., London Branch



5. EITHER (a) Name of purchaser / vendor (Note 1)


Children's Stores Holdings Limited



OR (b) if dealing for discretionary client(s), name of fund management
organisation






6. Reason for disclosure (Note 2)






(a) associate of



(i)  offeror (Note 3)



YES



(ii) offeree company



NO



Specify which category or categories of associate (1-8 overleaf)


Professional adviser to Offeror



If category (8), explain






(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the
class of relevant securities dealt in)



YES



Signed, for and on behalf of the party named in (4) above






(Also print name of signatory)


Simon newton



Telephone and Extension number


020 7767 1000




Note 1.



Specify owner, not nominee or vehicle company. If relevant, also identify
controller of owner, eg where an owner normally acts on instructions of a
controller



Note 2.



Disclosure might be made for more than one reason; if so, state all reasons.



Note 3.



Specify which offeror if there is more than one.



Note 4.



When an arrangement exists with any offeror, with the offeree company or with an
associate of any offeror or of the offeree company in relation to relevant
securities, details of such arrangement must be disclosed, as required by Note 6
on Rule 8.



Note 5.



It may be necessary, particularly when disclosing derivative transactions, to
append a sheet to this disclosure form so that all relevant information can be
given.



Note 6.



In the case of an average price bargain, each underlying trade should be
disclosed.

For full details of disclosure requirements, see Rule 8 of the Code. If in
doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:
020 7638 0129. Email: monitoring@disclosure.org.uk



DEFINITION OF ASSOCIATE

It is not practicable to define associate in terms which would cover all the
different relationships which may exist in an offer. The term associate is
intended to cover all persons (whether or not acting in concert) who directly or
indirectly own or deal in the shares of an offeror or the offeree company in an
offer and who have (in addition to their normal interests as shareholders) an
interest or potential interest, whether commercial, financial or personal, in
the outcome of the offer.

Without prejudice to the generality of the foregoing, the term associate will
normally include the following:-

(1)  an offeror's or the offeree company's parent, subsidiaries and fellow
subsidiaries, and their associated companies, and companies of which such
companies are associated companies (for this purpose ownership or control of 20%
or more of the equity share capital of a company is regarded as the test of
associated company status);

(2)  banks and financial and other professional advisers (including
stockbrokers)* to an offeror, the offeree company or any company covered in (1),
including persons controlling#, controlled by or under the same control as such
banks, financial and other professional advisers;

(3)  the directors (together with their close relatives and related trusts) of
an offeror, the offeree company or any company covered in (1);

(4)  the pension funds of an offeror, the offeree company or any company covered
in (1);

(5)  any investment company, unit trust or other person whose investments an
associate manages on a discretionary basis, in respect of the relevant
investment accounts;

(6)  a person who owns or controls 5% or more of any class of relevant
securities (as defined in paragraphs (a) to (d) in Note 2 on Rule 8) issued by
an offeror or an offeree company, including a person who as a result of any
transaction owns or controls 5% or more. When two or more persons act pursuant
to an agreement or understanding (formal or informal) to acquire or control such
securities, they will be deemed to be a single person for the purpose of this
paragraph. Such securities managed on a discretionary basis by an investment
management group will, unless otherwise agreed by the Panel, also be deemed to
be those of a single person (see Note 8 on Rule 8); and

(7)  a company having a material trading arrangement with an offeror or the
offeree company.

Paragraphs (1)-(7) are typical cases. Paragraph (8) below is a category to cover
associate status not within (1)-(7).

(8)   Other.



Notes

* References to a "bank" do not apply to a bank whose sole relationship with a
party to an offer is the  provision of normal commercial banking services or
such activities in connection with the offer as confirming that cash is
available, handling acceptances and other registration work.

References to "financial and other professional advisers (including
stockbrokers)", in relation to a party to an offer, do not include an
organisation which has stood down, because of a conflict of interest or
otherwise, from acting for that party in connection with the offer. If the
organisation is to have a continuing involvement with that party during the
offer, the Panel must be consulted.  Unless the Panel is satisfied that the
involvement is entirely unconnected with the offer, the above exclusion will not
normally apply.

# The normal test for whether a person is controlled by, controls or is under
the same control as another person will be by reference to the definition of
control contained in the Code.  There may be other circumstances which the Panel
will regard as giving rise to such a relationship (eg where a majority of the
equity share capital is owned by another person who does not have a majority of
the voting rights); in cases of doubt, the Panel should be consulted.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCNKFKQDBKDOOD

1 Year Hyloris Pharmaceuticals Chart

1 Year Hyloris Pharmaceuticals Chart

1 Month Hyloris Pharmaceuticals Chart

1 Month Hyloris Pharmaceuticals Chart